Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q41497028)
Watch
English
Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics.
scientific article published on 23 August 2017
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
title
Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
author
Yong Teng
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
author name string
Liwei Lang
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
Chloe Shay
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
Xiangdong Zhao
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
publication date
23 August 2017
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
published in
Journal of Experimental & Clinical Cancer Research
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
volume
36
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
issue
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
page(s)
112
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
cites work
Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Pharmacological modulation of oncogenic Ras by natural products and their derivatives: Renewed hope in the discovery of novel anti-Ras drugs.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Cancer statistics, 2016
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Increased expression of ARF GTPases in prostate cancer tissue
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Drugging the undruggable RAS: Mission possible?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Tumour heterogeneity and cancer cell plasticity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
LHRH Agonists for the Treatment of Prostate Cancer: 2012.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation factor 1 (Arf1) with potential for cancer therapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Inhibition of Ras for cancer treatment: the search continues
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
RAS pathways in prostate cancer - mediators of hormone resistance?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein-protein complexes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
MAP kinase signalling pathways in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
ARF proteins: roles in membrane traffic and beyond
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
The novel Ras antagonist, farnesylthiosalicylate, suppresses growth of prostate cancer in vitro
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Crystal structure of ARF1*Sec7 complexed with Brefeldin A and its implications for the guanine nucleotide exchange mechanism
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Infrequent RAS oncogene mutations in human prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
11 June 2018
Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5568197
retrieved
19 August 2018
Androgen receptor--an update of mechanisms of action in prostate cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/28830537
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1186/S13046-017-0583-4
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
Dimensions Publication ID
1091308901
0 references
PMC publication ID
5568197
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
PubMed publication ID
28830537
1 reference
stated in
Europe PubMed Central
PMC publication ID
5568197
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28830537%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit